Published in Am J Pathol on December 01, 1988
Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet (1989) 3.81
Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. Am J Hum Genet (1994) 1.70
Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J Cell Biol (1992) 1.64
Mechanosensitive channel properties and membrane mechanics in mouse dystrophic myotubes. J Physiol (2007) 1.55
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52
Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. Am J Hum Genet (1990) 1.48
Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci U S A (1989) 1.40
Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol (1992) 1.22
Caveolae regulation of mechanosensitive channel function in myotubes. PLoS One (2013) 0.87
Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis. J Korean Med Sci (2011) 0.83
A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers. J Med Genet (1992) 0.78
Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins. J Neurol (1993) 0.75
Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature (1961) 23.98
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention. Hum Genet (1984) 2.87
Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy. N Engl J Med (1987) 1.70
MUSCLE HISTOLOGY IN CARRIERS OF DUCHENNE MUSCULAR DYSTROPHY. J Med Genet (1965) 1.05
Duchenne muscular dystrophy: high frequency of deletions. Neurology (1988) 1.02
Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol (2001) 5.87
Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87
Searching MEDLINE for randomized clinical trials involving care of the newborn. Pediatrics (1989) 4.79
Circulating nucleic acids (CNAs) and cancer--a survey. Biochim Biophys Acta (2006) 4.60
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature (1989) 3.75
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell (1988) 2.94
Recent observations on the serology of syphilis. Br J Vener Dis (1980) 2.90
IUSTI: 2008 European Guidelines on the Management of Syphilis. Int J STD AIDS (2009) 2.85
Requirement of a membrane potential for the posttranslational transfer of proteins into mitochondria. Eur J Biochem (1982) 2.71
IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol (1990) 2.67
Action of cytochalasin D on cells of established lines. I. Early events. J Cell Biol (1974) 2.64
Primary lateral sclerosis. A clinical diagnosis reemerges. Arch Neurol (1988) 2.62
The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J Virol (1993) 2.58
Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet (1996) 2.57
Mitochondrial protein import: identification of processing peptidase and of PEP, a processing enhancing protein. Cell (1988) 2.57
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
Cloning and expression of human arylsulfatase A. J Biol Chem (1989) 2.55
Early prediction of poor outcome in extremely low birth weight infants by classification tree analysis. J Pediatr (2006) 2.49
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48
Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
The natural history of primary lateral sclerosis. Neurology (2006) 2.31
Transport into mitochondria and intramitochondrial sorting of the Fe/S protein of ubiquinol-cytochrome c reductase. Cell (1986) 2.21
Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature (1996) 2.20
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology (1992) 2.14
Attosecond spectroscopy in condensed matter. Nature (2007) 2.10
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology (2004) 2.09
Molecular characterization of a novel endonuclease (Xib) and possible involvement in lysosomal glycogen storage disorders. Exp Mol Pathol (1999) 2.09
Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology (1991) 2.07
Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regions. Acta Paediatr (2008) 2.04
A PC program for estimating organ dose and effective dose values in computed tomography. Eur Radiol (1999) 2.03
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology (1994) 2.00
Molecular forms of acetylcholine receptor. Effects of calcium ions and a sulfhydryl reagent on the occurrence of oligomers. Biochemistry (1977) 1.98
Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology (1990) 1.97
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem (1989) 1.94
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet (1992) 1.94
Purification and some properties of five endo-1,4-beta-D-xylanases and a beta-D-xylosidase produced by a strain of Aspergillus niger. Can J Biochem (1979) 1.93
Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology (1992) 1.93
Potential contribution of consumers to an integrated health care system. Public Health Rep (1976) 1.90
Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy (2000) 1.90
Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Natl Acad Sci U S A (1989) 1.88
The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology (1990) 1.87
Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2000) 1.84
Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry (2000) 1.82
Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol (1983) 1.82
TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc Natl Acad Sci U S A (1994) 1.80
Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. QJM (2001) 1.79
Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol (1997) 1.78
Isolation of a cDNA clone encoding subunit IV of human cytochrome c oxidase. Gene (1987) 1.76
Respiratory distress as the initial manifestation of Werdnig-Hoffmann disease. Pediatrics (1974) 1.76
Action of cytochalasin D on cells of established lines. II. Cortex and microfilaments. J Cell Biol (1974) 1.74
Cerebellar ataxia and coenzyme Q10 deficiency. Neurology (2003) 1.73
Processing peptidase of Neurospora mitochondria. Two-step cleavage of imported ATPase subunit 9. Eur J Biochem (1984) 1.73
In vitro binding of plasma membrane-coated vesicle adaptors to the cytoplasmic domain of lysosomal acid phosphatase. J Biol Chem (1993) 1.72
The essential tyrosine of the internalization signal in lysosomal acid phosphatase is part of a beta turn. Cell (1991) 1.72
Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology (1999) 1.72
The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J Biol Chem (2000) 1.71
Diagnostic tests for bacterial infection from birth to 90 days--a systematic review. Arch Dis Child Fetal Neonatal Ed (1998) 1.70
Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve (1996) 1.69
Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem (1990) 1.69
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology (2001) 1.68
GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology (2000) 1.64
Protoplast transformation in coryneform bacteria and introduction of an alpha-amylase gene from Bacillus amyloliquefaciens into Brevibacterium lactofermentum. Appl Environ Microbiol (1986) 1.63
"Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg (1988) 1.63
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology (2007) 1.63
Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology (1990) 1.61
Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection (2001) 1.60
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol (1991) 1.60
A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr (1994) 1.59
Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology (1997) 1.58
Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology (1992) 1.58
Atrial size reduction as a predictor of the success of radiofrequency maze procedure for chronic atrial fibrillation in patients undergoing concomitant valvular surgery. J Cardiovasc Electrophysiol (2001) 1.58
Human lysosomal acid phosphatase: cloning, expression and chromosomal assignment. EMBO J (1988) 1.57
Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. J Clin Virol (1999) 1.57
Apoptotic features accompany acute quadriplegic myopathy. Neurology (2000) 1.57
Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol (2001) 1.55
Lymphoproliferative disorders and motor neuron disease: an update. Neurology (1997) 1.54
The race-specific elicitor, NIP1, from the barley pathogen, Rhynchosporium secalis, determines avirulence on host plants of the Rrs1 resistance genotype. EMBO J (1995) 1.54
Heteroplasmy of mitochondrial genomes in clonal cultures from patients with Kearns-Sayre syndrome. Biochem Biophys Res Commun (1989) 1.52
Portal vein filling: a rare complication associated with ERCP for endoscopic biliary stent placement. Gastrointest Endosc (1992) 1.51
Polyglucosan body disease. Muscle Nerve (1991) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol (2012) 1.49